Dept. Biomedical Engineering, Columbia University, 351 ET, 500 W 120th St., New York, United States;
Dept. Biomedical Engineering, Columbia University, 351 ET, 500 W 120th St., New York, United States;
Dpt. Internal Medicine, Columbia University, 177 Fort Washington Avenue, New York, United States;
Dept. Biomedical Engineering, Columbia University, 351 ET, 500 W 120th St., New York, United States;
Herbert Irving Comprehensive Cancer Center, 161 Fort Washington Avenue, New York, United States;
Dpt. Internal Medicine, Columbia University, 177 Fort Washington Avenue, New York, United States;
Dpt. Internal Medicine, Columbia University, 177 Fort Washington Avenue, New York, United States;
Dpt. Internal Medicine, Columbia University, 177 Fort Washington Avenue, New York, United States;
Dpt. Internal Medicine, Columbia University, 177 Fort Washington Avenue, New York, United States;
Dept. Biomedical Engineering, Columbia University, 351 ET, 500 W 120th St., New York, United States;
Breast imaging; tumor response; neoadjuvant chemotherapy; diffuse optical tomography; contralateral normal breast; oxygen saturation;
机译:基线肿瘤血氧饱和度与接受新辅助化疗的乳腺癌患者的病理完全缓解相关
机译:Neoadjuvant化疗后乳腺癌癌症分期和病理完全反应的残余癌症负担比较:I-Spy 1试验结果(CalgB 150007/150012; acrin 6657)
机译:剩余癌症负担的比较,美国联合癌症癌症委员会乳腺癌癌症分期和病理完全反应疗法:I-Spy 1试验结果(Calgb 150007/150012; acrin 6657)
机译:基线氧饱和度与新辅助化疗的响应病理完全响应者与广泛的残留癌病例相比
机译:在乳腺癌新辅助化疗后使用术前Mri引导的活检来预测病理完全缓解
机译:基线肿瘤氧饱和度与接受新辅助化疗的乳腺癌患者的病理完全反应相关联
机译:剩余癌症负担的比较,美国联合癌症癌症委员会乳腺癌癌症分期和病理完全反应疗法:I-Spy 1试验结果(Calgb 150007/150012; acrin 6657)